Burrows Scott L
Chief Financial Officer
CIK: 1853327
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Spyre Therapeutics, Inc. (SYRE) | M | 2,500 | $14.50 | $36,250.00 | View Details Filing |
| Mar 3, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 2,300 | $40.56 | $93,288.00 | View Details Filing |
| Mar 3, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 200 | $41.66 | $8,332.00 | View Details Filing |
| Mar 3, 2026 | Spyre Therapeutics, Inc. (SYRE) | M | 2,500 | $0.00 | $0.00 | View Details Filing |
| Jan 9, 2026 | Spyre Therapeutics, Inc. (SYRE) | A | 140,000 | $0.00 | $0.00 | View Details Filing |